Bleichroeder LP Cue Biopharma, Inc. Transaction History

Bleichroeder LP

$296 Million
Q3 2024

A detailed history of Bleichroeder LP transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Bleichroeder LP holds 4,997,240 shares of CUE stock, worth $6.4 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares

4,997,240

Previous 2,861,606 74.63%

Holding current value

$6.4 Million

Previous $3.55 Million 7.02%

% of portfolio

1.28%

Previous 1.28%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.45 - $1.08 $961,035 - $2.31 Million	2,135,634 Added 74.63%	4,997,240 $3.8 Million
Q2 2024 Aug 13, 2024	BUY	$1.24 - $2.18 $132,156 - $232,340	106,578 Added 3.87%	2,861,606 $3.55 Million
Q1 2024 May 14, 2024	BUY	$1.77 - $3.09 $1.77 Million - $3.09 Million	1,000,000 Added 56.98%	2,755,028 $5.21 Million
Q4 2023 Feb 12, 2024	BUY	$1.72 - $3.1 $1.72 Million - $3.1 Million	1,000,000 Added 132.45%	1,755,028 $4.63 Million
Q1 2023 May 12, 2023	SELL	$2.41 - $3.74 $256,062 - $397,375	-106,250 Reduced 12.34%	755,028 $2.7 Million
Q4 2022 Feb 13, 2023	BUY	$2.39 - $3.95 $732,004 - $1.21 Million	306,278 Added 55.19%	861,278 $2.45 Million
Q2 2022 Aug 10, 2022	BUY	$2.49 - $5.92 $7,470 - $17,760	3,000 Added 0.54%	555,000 $1.38 Million
Q1 2022 May 11, 2022	BUY	$4.41 - $12.28 $1.55 Million - $4.32 Million	352,000 Added 176.0%	552,000 $2.69 Million
Q4 2021 Feb 10, 2022	BUY	$10.86 - $17.85 $271,500 - $446,250	25,000 Added 14.29%	200,000 $2.26 Million
Q2 2021 Aug 16, 2021	BUY	$10.9 - $14.53 $1.09 Million - $1.45 Million	100,000 Added 133.33%	175,000 $2.04 Million
Q4 2020 Feb 10, 2021	SELL	$11.12 - $16.4 $833,999 - $1.23 Million	-75,000 Reduced 50.0%	75,000 $938,000
Q3 2020 Nov 12, 2020	SELL	$15.05 - $23.54 $225,750 - $353,100	-15,000 Reduced 9.09%	150,000 $2.26 Million
Q2 2020 Aug 12, 2020	BUY	$12.7 - $30.73 $2.07 Million - $5 Million	162,659 Added 6948.27%	165,000 $4.04 Million
Q1 2020 May 14, 2020	SELL	$9.85 - $22.27 $1.6 Million - $3.62 Million	-162,659 Reduced 98.58%	2,341 $0
Q4 2019 Feb 14, 2020	BUY	$7.06 - $17.47 $1.16 Million - $2.88 Million	165,000 New	165,000 $2.62 Million

Others Institutions Holding CUE

# of Institutions

Shares Held

14M

Call Options Held

14.4K

Put Options Held

2.6K

View Full List

About Cue Biopharma, Inc.

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $45.3M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

More about CUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleichroeder LP, based on Form 13F filings with the SEC.

News

Stay updated on Bleichroeder LP with notifications on news.

Account